Jeff Yass’s Microbot Medical MBOT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$647K Buy
539,047
+13,220
+3% +$21.3K ﹤0.01% 9058
2026
Q2
$1.03M Sell
525,827
-398,480
-43% -$812K ﹤0.01% 8134
2026
Q1
$2.23M Sell
924,307
-320,816
-26% -$717K ﹤0.01% 5926
2025
Q4
$2.49M Sell
1,245,123
-4,902
-0.4% -$11.6K ﹤0.01% 5205
2025
Q3
$3.81M Buy
1,250,025
+1,218,186
+3,826% +$3.8M ﹤0.01% 4551
2025
Q2
$80.2K Sell
31,839
-72,341
-69% -$173K ﹤0.01% 11906
2025
Q1
$157K Buy
104,180
+74,452
+250% +$132K ﹤0.01% 11187
2024
Q4
$33.3K Buy
+29,728
New +$29.1K ﹤0.01% 11816
2024
Q3
– Sell
-10,404
Closed -$10.6K – 12591
2024
Q2
$10.6K Buy
+10,404
New +$10.7K ﹤0.01% 11768
2016
Q3
– Sell
-153
Closed -$8K – 8777
2016
Q2
$8K Buy
+153
New +$44.1K ﹤0.01% 8430
2015
Q4
– Sell
-12
Closed -$8K – 9728
2015
Q3
$8K Buy
+12
New +$9.12K ﹤0.01% 9550
2014
Q4
– Sell
-990
Closed -$2.02M – 9897
2014
Q3
$2.02M Buy
+990
New +$2.61M ﹤0.01% 4603

Other funds holding MBOT

Jeff Yass's MBOT Position: Q3 2026 in Review

Jeff Yass increased its Microbot Medical (MBOT) stake by 2.5% in Q3 2026, buying an estimated $21.3K and bringing the position to 539,047 shares worth $647K. The position accounts for ﹤0.01% of the portfolio, ranked #9058.

Jeff Yass first reported a position in MBOT in Q3 2014 and has held it in 12 quarters since. The position peaked at $3.81M in Q3 2025. 73 funds tracked by Wall St. Rank hold MBOT as of Q3 2026.

  • Jeff Yass held 539,047 shares of Microbot Medical worth $647K as of Q3 2026.
  • Jeff Yass bought 13,220 Microbot Medical shares in Q3 2026, an estimated $21.3K.
  • Microbot Medical made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #9058 holding.
  • Jeff Yass first reported a position in Microbot Medical in Q3 2014 and has held it in 12 quarters since.
  • Jeff Yass's Microbot Medical position peaked at $3.81M in Q3 2025.
  • 73 funds tracked by Wall St. Rank held Microbot Medical as of Q3 2026.

Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.